Angelos Stergiou's Blog
About Dr. Angelos Stergiou
Dr. Angelos Stergiou is the CEO and Vice Chairman of SELLAS Life Sciences Group, a leading bio pharmaceutical neoepitope immunotherapy company that is advancing innovative cancer therapies. Throughout his career, Dr. Angelos Stergiou has collaborated with some of the world’s top academic institutions on clinical research endeavors. The Mayo Clinic, University of Heidelberg, New York University, Harvard University, MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center and Cleveland Clinic represent some of many such institutions that he has worked with.